Markets
Stocks
Mutual Funds & ETF's
Sectors
Tools
Overview
Market News
Currencies
International
Search InvestCenter
Recent Quotes
View Full List
My Watchlist
Create Watchlist
Top Indices
DJI
Nasdaq Composite
SPX
My Portfolio
S&P Biotech SPDR
(NY:
XBI
)
101.51
+1.37 (+1.37%)
Official Closing Price
Updated: 8:00 PM EDT, Aug 23, 2024
Add to My Watchlist
Quote
Overview
Detailed Quote
Charting
Historical Prices
News
All News
News Headlines
Press Releases
Research
Quarterly Reports
Insider Filings
Other Filings
Headline News about S&P Biotech SPDR
< Previous
1
2
...
4
5
6
7
8
9
10
11
Next >
This Biotech Looks Good With Increased M&A activity
May 20, 2022
Fierce Biotech backs this up: “Biopharmas have $1.7 trillion to spend on deals this year, and big players like Novartis, Pfizer and Merck & Co. have made it pretty clear they’re on the hunt for...
Via
Talk Markets
The “Mystery Liquidator Revealed” Stock Market (And Sentiment Results)
May 19, 2022
In this week’s AAII Sentiment Survey result, Bullish Percent ticked up a hair to 26% this week from 24.3% last week. Bearish Percent rose to 50.4% from 49%.
Via
Talk Markets
Large Cap Biopharmaceuticals: Provide Growth, Value And Yield
May 16, 2022
Now that all major biopharmaceutical earnings are in, we can review the financial metrics and see if our portfolio needs re-balancing.
Via
Talk Markets
When Will The Stock Market Stop Falling?
May 12, 2022
Stocks have fallen dramatically just this past week, is a bottom near?
Via
Talk Markets
Stocks Tank On May 11 With No Bottom In Sight
May 11, 2022
Despite the sharp decline, the VIX finished down on the day at 32.5. It tells us there was “real” selling in the market today.
Via
Talk Markets
The “Shake It Off” Stock Market (And Sentiment Results)
April 07, 2022
We may be close to a short term peak in yields – bottom in bonds
Via
Talk Markets
XBI Biotech 15% Potential
February 08, 2022
The Biotech Sector ETF had a very nice rally, a bull flag, and ended up having the second half of the move to the upside.
Via
Talk Markets
7 Biotech Stocks With Key Catalysts for May
May 11, 2022
The beaten-down state of biotech stocks is a major pulling point for investors who are aiming for market-leading returns.
Via
InvestorPlace
Should Biotech Be On The Critical List?
May 11, 2022
The risk-off market has played havoc with the biotechs where the fundamentals have not changed as much as the valuation.
Via
Talk Markets
“Threading The Needle” Stock Market (And Sentiment Results)
May 05, 2022
Two weeks ago AAII sentiment survey dropped to a 30 year low at 15.8% bullish. Last week it ticked up modestly to 16.4%.
Via
Talk Markets
7 Monster Stock Market Predictions For The Week Of April 25
April 23, 2022
The week ending April 22 was brutal. The S&P 500 fell by nearly 2.75%, but things were much worse than that. Powell unleashed hell when he noted that a 50 bps rate hike was on the table for the FOMC...
Via
Talk Markets
The “magic Chart” Stock Market (And Sentiment Results)
April 21, 2022
We have now come to a point Where the market has priced in more rate hikes than are likely to occur.
Via
Talk Markets
4 Undervalued Biotech Stocks to Add to Your Buy List
April 20, 2022
These biotech stocks have seen their valuations tumble in the year-to-date sell-off. But they have the wherewithal to bounce big and generate decent, market-beating returns.
Via
InvestorPlace
Healthcare Stocks Lead the Way Up as the Market Fades
April 11, 2022
With inflation and energy costs soaring, the Fed ever threatening with higher rates and headlines from the war in Ukraine investors are seeking more defensive positions.
Via
Talk Markets
Recession Fears are Creating a Golden Opportunity for Biotech Stocks
April 08, 2022
Biotech stocks are hard for novice investors to successfully profit from, but it's worth your time to learn the techniques now.
Via
InvestorPlace
Layoffs at Bluebird Bio Highlight the Current Struggles of Biotech Picks
April 08, 2022
Cash will be king in biotech picks like BLUE stock as governments slow approvals and reimbursements of new gene therapies.
Via
InvestorPlace
Sunshine Biopharma Stock Triples on Positive mRNA Cancer Treatment Results
April 05, 2022
SBFM stock tripled to $6.53 on Tuesday after revealing that two of its newly designed mRNA molecules are effective in destroying cancer cells.
Via
InvestorPlace
Good Entry Point for Biotech Stocks
April 04, 2022
Life science and biotech stocks had a good week with the most well-known ETFs up 3-4% for the week and off recent bottoms.
Via
Talk Markets
CNBC's Final Call: Newmont, Biotech ETF And This Energy Stock
April 04, 2022
On CNBC's "The Final Call," Carter Worth recommended Newmont Corporation (NYSE: NEM). The stock has jumped almost 36% year to date.
Via
Benzinga
Acadia: Helping With Alzheimers And Parkinsons
April 03, 2022
Things always change fast in biotech, but until recently things have been moving consistently to the downside. It’s been a while, but we believe this is finally over. And we believe Acadia...
Via
Talk Markets
Biotech Funds and ETFs Continue to Lag
March 28, 2022
It’s no secret that market sectors driving inflation are leading the market. With the US economy still strong and the War in Ukraine limiting supply of nat gas and raw materials, producer costs are...
Via
Talk Markets
How do Biotechnology Funds and ETFs Perform Over Five Years?
March 21, 2022
Biotech investing can be difficult for short-term traders but can offer good returns over five years if balanced with other healthcare positions like the XLV.
Via
Talk Markets
AskSlim Market Week - Friday, March 18
March 18, 2022
Technical and cycle analysis, and market commentary.
Via
Talk Markets
3 Market ETF Stocks to Buy This Week on Fed Jitters
March 14, 2022
The bears have two major tailwinds and the Fed is one. Here are 3 ETF stocks to buy into a potential relief rally after the event blows over.
Via
InvestorPlace
Tough Slogging Ahead for Investors, Diversification is Important
March 07, 2022
Speculative small/mid-cap biotech stocks hit new lows this past week with the XBI at a “triple bottom” about the $84 level only 10 points above the March 2020 lows.
Via
Talk Markets
3 Moonshot Stocks Insiders Are Buying. What Do They Know?
February 25, 2022
Biotech stocks aren't a sure thing, but one good sign is insiders buying up shares. These three all offer that enticing feature.
Via
InvestorPlace
3 Desirable Drug Stocks With Very Promising Pipelines
February 16, 2022
Drug makers with superb pipelines are likely to deliver great returns for long-term investors. Here are three drug stocks to consider.
Via
InvestorPlace
Large Cap Biopharma- Well Positioned For Choppy Markets
February 14, 2022
If the past week is any indicator large-cap biopharma stocks are a good place to hide from the turbulence of 2022 markets.
Via
Talk Markets
The Dean Martin, “You’re Nobody ‘Till Somebody Loves You” Stock Market (And Sentiment Results)…
February 11, 2022
China Tech (Alibaba) and Biotech have been the two least-loved sectors in recent weeks, but we believe this is changing.
Via
Talk Markets
Small Cap Biotech Stocks: Is it time to start trading?
January 31, 2022
It’s time to trade beaten-up small cap biotech stocks.
Via
Talk Markets
< Previous
1
2
...
4
5
6
7
8
9
10
11
Next >
Data & News supplied by
www.cloudquote.io
Stock quotes supplied by Barchart
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the following
Privacy Policy
and
Terms and Conditions
.